After approvals for one of cancer's 'undruggable' targets, research into new KRAS therapies booms: #AACR24
For cancer researchers, the potential was as obvious as the problem.
Mutations to the KRAS gene drive nearly a third of all cancers. A laundry …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
